Skip to content

DR. JAN VAN HECKE

Active
Private limited companyfounded 201114 yrs activeSint-Pietersvliet 3, 2000 Antwerpen, BelgiumKBO/BCE: BE 0841.879.232

DR. JAN VAN HECKE has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €671k and a net result of €78k. Equity is growing by ~12.4% per year across the filed fiscal years. Its solvency ranks better than 80% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2024
85 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability82▼-15
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 26.32 against 20.97 in 2023; short-term debt: 2.7% and cash: 1.5% of total assets), and 11.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 14 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
88.3%
Return on assets
10.3%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 06-08-2025, 6 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
6 d late
2023
57 d late
2022
2 d late
2021
3 d early
2020
17 d early
2019
31 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€671k▼ 1.0%
2023 · €678k
2018: €382k 2019: €373k 2020: €418k 2021: €581k 2022: €731k 2023: €678k
2018 → 2024
Total assets
€759k▼ 2.8%
2023 · €781k
2018: €593k 2019: €554k 2020: €536k 2021: €716k 2022: €867k 2023: €781k
2018 → 2024
Net result
€78k▼ 55.7%
2023 · €176k
2018: €85k 2019: €-8k 2020: €97k 2021: €163k 2022: €150k 2023: €176k
2018 → 2024
Working capital
€520k▼ 0.1%
2023 · €520k
2018: €225k 2019: €224k 2020: €281k 2021: €441k 2022: €597k 2023: €520k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€418k-€581k▲ 39.1%€731k▲ 25.7%€678k▼ 7.3%€671k▼ 1.0%
Operating result€121k-€219k▲ 81.0%€188k▼ 14.3%€231k▲ 23.1%€87k▼ 62.2%
Net result€97k-€163k▲ 68.8%€150k▼ 8.5%€176k▲ 17.7%€78k▼ 55.7%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2020: €121k€121kNet result 2020: €97k€97kOperating result 2021: €219k€219kNet result 2021: €163k€163kOperating result 2022: €188k€188kNet result 2022: €150k€150kOperating result 2023: €231k€231kNet result 2023: €176k€176kOperating result 2024: €87k€87kNet result 2024: €78k€78k20202021202220232024
The operating result falls in 2024; 2024 is 62% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €759k
Fixed assets €219k▼ 6.9%
Current assets €541k▼ 1.1%
Equity and liabilities €759k
Equity €671k▼ 1.0%
Debt €89k▼ 14.7%
The debt ratio falls from 13.3% to 11.7%. Equity and debt are lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€107k
2023 · €249k
Cash flow
€98k
2023 · €195k
Solvency
88.3%
2023 · 86.7%
Current ratio
26.32
2023 · 20.97
Quick ratio
26.32
2023 · 20.97
Debt / equity
0.13
2023 · 0.15
ROE
11.6%
2023 · 26.0%
ROA
10.3%
2023 · 22.5%
Interest coverage
27.94
2023 · 59.74
Debt
€89k
2023 · €104k
Debt ≤ 1 year
€21k
2023 · €26k
Debt > 1 year
€68k
2023 · €78k
Income taxes
€33k
2023 · €76k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€781k€759k
Fixed assets21/28€235k€219k
Tangible fixed assets22/27€235k€219k
Land and buildings22€211k€194k
Furniture and vehicles24€17k€17k
Other tangible fixed assets26€7k€7k=
Current assets29/58€547k€541k
Amounts receivable within one year40/41€441k€474k
Trade receivables40€3k€4k
Other amounts receivable41€438k€470k
Cash at bank and in hand54/58€20k€12k
Deferred charges and accrued income490/1€86k€55k
Equity and liabilities
Total equity and liabilities10/49€781k€759k
Equity10/15€678k€671k
Contributions10/11€13k€13k=
Reserves13€665k€658k
Distributable reserves133€665k€658k
Amounts payable17/49€104k€89k
Amounts payable after more than one year17€78k€68k
Financial debts170/4€78k€68k
Amounts payable within one year42/48€26k€21k
Current portion of amounts payable after more than one year42€9k€10k
Trade debts44€693€5k
Suppliers440/4€693€5k
Taxes, remuneration and social security45€16k€6k
Taxes450/3€16k€96
Remuneration and social security454/9-€6k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€20k
Other operating charges640/8€1k€3k
Non-recurring operating charges66A€684-
Gross operating margin9900€251k€109k
Operating profit (loss)9901€231k€87k
Financial income75/76B€25k€27k
Recurring financial income75€25k€27k
Financial charges65/66B€4k€4k
Recurring financial charges65€4k€4k
Profit (loss) for the period before taxes9903€252k€111k
Income taxes67/77€76k€33k
Profit (loss) for the period9904€176k€78k
Profit (loss) for the period to be appropriated9905€176k€78k
Appropriation of the result
Profit (loss) to be appropriated9906€176k€78k
Transfer from equity791/2€229k€85k
Transfer to equity691/2€176k€78k
To other reserves6921€176k€78k
Profit to be distributed694/7€229k€85k
Return on contributions (dividend)694€229k€85k

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
06-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 6 days late
2024
26-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 57 days late
2023
31-12
Financial Highest result since 2018net €176k ▲17.7%
Operating result €231k, net result €176k, both a record.
02-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 2 days late
2022
28-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €500kEq €581k ▲39.1%
2 profitable years in a row build equity to €581k.
14-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Back to profitnet €97k
Net result €97k after one loss-making year.
31-12
Financial Liquidity times 5current ratio 21.50
Current ratio from 4.31 to 21.50; short-term debt falls from €68k to €14k.
30-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Weakest financial yearnet €-8k ▼110%
Net result drops to €-8k, the lowest in the series; recovery starts the following year.
29-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 29 days late
2018
11-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
26-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
17-08
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
no sitting director, no change since 2023
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
01-12-2023 Resigned as Director
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Sint-Pietersvliet 32000 Antwerpen
Ground area
1,139 m²
Building footprint
226 m²
Volume, LiDAR
2,511 m³
Parcel 11002A0268/00B000, Flanders · tallest building 14.3 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DR. JAN VAN HECKE
Sint-Pietersvliet 3, 2000 AntwerpenSpecialist medical practice
since 20122.205.606.586
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11002A0268/00B000 Flanders 1,139 m² 1 · 226 m² 14.2 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,187 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded12-12-2011
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.